Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02551822 · ClinicalTrials.gov registry record · NA
Cycling Versus Continuous Mode in Neuromodulator Programming
A NA study, sponsored by University of New Mexico.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT02551822 is a NA study that has completed, run by University of New Mexico. The registered enrollment target is 32 participants.
The verdict
NCT02551822, a NA study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The investigators objective is to compare patient outcomes as changes in validated symptom measures of overactive bladder, the Overactive Bladder Questionnaire Short Form (OABq-SF) symptom scale, between women who are set on cycling versus continuous programs for their neuromodulator. Specifically, the investigators propose to perform a randomized double blind crossover study in women who are successfully treated with neuromodulation to either continuous or cycling mode on the modulator and compare differences between groups on the validated OABq-SF symptom questionnaire. In addition, the investigators will compare differences in urinary frequency and pad counts between women randomized to cycling versus continuous stimulation as measured by a 3 day voiding diary. This investigation will provide evidence-based guidelines for neuromodulator programming.
Interventions
- DEVICE sacral neuromodulator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2012-07 |
| Est. Completion | 2015-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02551822
The ClinicalTrials.gov registry entry for NCT02551822 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which sacral neuromodulator is the first listed.
NCT02551822 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02551822 about?
NCT02551822 is a clinical study titled "Cycling Versus Continuous Mode in Neuromodulator Programming". The investigators objective is to compare patient outcomes as changes in validated symptom measures of overactive bladder, the Overactive Bladder Questionnaire Short Form (OABq-SF) symptom scale, between women who are set on cycling versus continuous programs for their neuromodulator. Specifically, ...
What is the current status of trial NCT02551822?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2012-07. Estimated completion is 2015-11.
What interventions are being tested in trial NCT02551822?
The interventions under investigation include: sacral neuromodulator (DEVICE).
Who is sponsoring clinical trial NCT02551822?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.